Combination immunotherapies for treatment of cancer
AssigneePrimevax Immuno-Oncology, Inc.
InventorBruce W. Lyday
Life of this patent
Estimating the term…
Abstract
Described herein are compositions and methods for treating a disease, particularly a cancer, with an immune checkpoint modulatory agent and a strain of an Arbovirus or a strain of an Alphavirus. Also provided herein are also methods for combination therapy comprising administration of an immune checkpoint modulatory agent, tumor antigen primed dendritic cells and an Alphavirus or an Arbovirus.
Claims9
A method for treatment of cancer, comprising administering a Dengue virus to a subject having received an immune checkpoint modulatory agent, wherein the immune checkpoint modulatory agent is an antibody against PD-L1.
Dependencies are inferred from the claim text.